Questcor Pharmaceuticals (NASDAQ: QCOR) announced its earnings results on Tuesday. The company reported $1.03 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.90 by $0.13. The company had revenue of $160.50 million for the quarter, compared to the consensus estimate of $142.58 million. During the same quarter last year, the company posted $0.47 earnings per share. Questcor Pharmaceuticals’s revenue was up 112.6% compared to the same quarter last year.
A number of research firms have also recently commented on QCOR. Analysts at Janney Montgomery Scott initiated coverage on shares of Questcor Pharmaceuticals in a research note to investors on Thursday, February 21st. They set a “buy” rating and a $40.00 price target on the stock. On a related note, analysts at TheStreet upgraded shares of Questcor Pharmaceuticals from a “hold” rating to a “buy” rating in a research note to investors on Thursday, February 21st. Finally, analysts at Mizuho upgraded shares of Questcor Pharmaceuticals from a “neutral” rating to a “buy” rating in a research note to investors on Thursday, February 21st. They now have a $41.00 price target on the stock, up previously from $28.00.
Six investment analysts have rated the stock with a buy rating, and three have assigned a hold rating to the company. Questcor Pharmaceuticals currently has an average rating of “overweight” and an average price target of $44.71.
Shares of Questcor Pharmaceuticals (QCOR) traded up 5.19% during mid-day trading on Tuesday, hitting $32.66. Questcor Pharmaceuticals (QCOR) has a one year low of $17.25 and a one year high of $58.91. The stock’s 50-day moving average is currently $26.91. The company has a market cap of $1.916 billion and a P/E ratio of 12.00.
The company also recently announced a quarterly dividend, which is scheduled for Tuesday, April 30th. Shareholders of record on Monday, April 22nd will be paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 3.06%.
Questcor Pharmaceuticals, Inc. (Questcor) is a biopharmaceutical company. The Company’s primary product is HP.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.